Login / Signup

Patient-targeted education (ePRO-E) to increase ePRO intent within an Alliance clinical trial (A221805-SI1).

Ellen M Lavoie SmithYoumin ChoShauna HillmanMary R ScottElizabeth HarlosRachel WillsCharles LoprinziChristina M WilsonDavid Zahrieh
Published in: JNCI cancer spectrum (2024)
ePRO-E exposure increased ePRO intent. High technology attitudes scores were associated with ePRO selection. Since the ePRO survey submission rate was low, additional strategies are needed to promote high-quality data submission.
Keyphrases
  • clinical trial
  • healthcare
  • mental health
  • case report
  • randomized controlled trial
  • machine learning
  • cancer therapy
  • study protocol
  • open label
  • big data
  • quality improvement
  • drug delivery
  • placebo controlled